Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy.

Chang, E

Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy. [electronic resource] - Journal of immunotherapy (Hagerstown, Md. : 1997) - 88-90 p. digital

Publication Type: Comparative Study; Journal Article

1524-9557

10.1097/00002371-200101000-00010 doi


Adolescent
Adult
Aged
Antineoplastic Agents--administration & dosage
Child
Demography
Disease Susceptibility
Drug Resistance, Neoplasm
Female
Humans
Injections, Intravenous
Interleukin-2--administration & dosage
Male
Melanoma--drug therapy
Middle Aged
Skin Neoplasms--drug therapy
Treatment Outcome